Source: Annual Congress 2004 - Thoracic oncology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
D. Dworakowska, E. Bryl, M. Soroczynska, J. M. Witkowski, M. Lapinski, A. Mital, D. Tomaszewski, R. Dworakowski, E. Kazimierska, J. Skokowski, E. Czestochowska (Gdansk, Poland). The death receptor Fas in CD3+T cells in patients with non-small cell lung cancer. Eur Respir J 2004; 24: Suppl. 48, 4106

Member's Comments

No comment yet.

Related content which might interest you: Lower APCR correlates with apoptotic activation of CD8+T cells in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 356s Year: 2004 Expression of Her-2/neu and Bcl-2 in patients with non-small cell lung cancer Source: International Congress 2017 – Gene signatures in bronchial diseases Year: 2017 Deguelin enhances chemosensitivity of non-small cell lung cancer cells Source: Eur Respir J 2006; 28: Suppl. 50, 336s Year: 2006 Survivin expression in non-small cell lung cancer Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 KPNB1-mediated PD-L1 nuclear translocation promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signalling pathway Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 Role of EBUS-TBNA in the study of PD-L1 expression in patients with non-small cell lung cancer (NSCLC) Source: Virtual Congress 2020 – Endobronchial ultrasound: from rookie to pro Year: 2020 IRP2 as a potential modulator of cell proliferation, apoptosis and prognosis in nonsmall cell lung cancer Source: Eur Respir J , 49 (4)  1600711; DOI: 10.1183/13993003.00711-2016 Year: 2017 Impact of PD-L1 expression levels on the response to pembrolizumab in metastatic non-small cell lung cancer> Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021 Prognostic significance of CD-3 T-cells and NK cells in surgically treated non-small cell lung carcinomas Source: Eur Respir J 2005; 26: Suppl. 49, 328s Year: 2005 Relationship between Cancer-associated fibroblast and programmed death ligand 1 expression in non-small cell lung cancer Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020 HIF-1α modulation by topoisomerase inhibitors in A549, a non-small cell lung cancer cell line Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007 Magnolol can induce apoptosis in non-small cell lung cancer via caspase-independent pathway Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Mitochondrial depolarization and annexin V binding in CD3+T cells in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 357s Year: 2004 Evaluate soluble PD-L1 in plasma in advanced stage non-small cell lung cancer patients Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 Toll-like receptor 3 is up-regulated and enhances anti-proliferative function in human non-small cell lung cancer Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs Year: 2008 Ki-67 in non-small cell lung cancer Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012 Ras peptide-specific vaccination in patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2006 - Lung cancer treatment Year: 2006 p-53 and HER2/neu expression in relation to chemotherapy response in patients with non-small cell lung cancer Source: Annual Congress 2007 - Novel genetic markers in pathology Year: 2007 TNFα as a prognostic factor in surgically treated non-small cell lung carcinomas Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005